Skip to content
10-K

Annual Report

Bone Biologics Corp BBLG BBLGW

0001493152-25-008383

← back to feed
Filed
Feb 26, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 19, 2025 3.27M sh
Shares Diluted FY 2024 · Dec 31, 2023 263.14K sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$9.56M
Current Liabilities FY 2024 · Dec 31, 2023 $831.4K
Total Liabilities FY 2024 · Dec 31, 2023 $831.4K
Current Assets FY 2024 · Dec 31, 2023 $3.74M
Total Assets FY 2024 · Dec 31, 2023 $3.74M
Eps Diluted FY 2024 · Dec 31, 2023 −$34.01
Eps Basic FY 2024 · Dec 31, 2023 −$34.01
Sga Expense FY 2024 · Dec 31, 2023 $2.52M
Rd Expense FY 2024 · Dec 31, 2023 $6.91M
Net Income FY 2024 · Dec 31, 2023 −$8.95M
Operating Income FY 2024 · Dec 31, 2023 −$9.43M
Stockholders Equity FY 2024 · Dec 31, 2022 $5.95M